Cite
HARVARD Citation
Yang, J. et al. (2016). The efficacy and safety of platinum plus gemcitabine (PG) chemotherapy with or without molecular targeted agent (MTA) in first-line treatment of non-small cell lung cancer (NSCLC). Medicine. 95 (50), p. . [Online].